RE:RE:Bumping up my own posts....Dmiiek001 wrote:
"read your post on the hexo page. My question is why do you think cura or trul would be interested in any canadian LP? If you combine illinois, michigan and arizona you have approx the same annual weed sales as all of canada. There is way bigger fish to fry in the US then there is in canada. That alone tells me that no us mso would even consider buying canopy or aphria just to riun their balance sheets."
First, to address your overall sentiment of why goin into Canada is strategically sound. Your right they don't have to go into the Canadian market IF they don't think it's proftiable to do so. But imo it would tactically wrong & short sighted. For the same reasons a bverage company like Pepsi or Coke went there, for the same reason many other US based goods & services companies have gone there. Along with many Pharmaceuticals ops who have done as well. There's a valid reason why they have all set up shop there. Don't forget Canada may not have the massive influence or country appeal like the US, but it's another California in terms of population & abundant personal disposable income close by, with Govt regulation in pace ready for consumption. But you're corrent on one specific point, they don't have to supersize by buying out soley a Canadian operation like Weed, which does have a good amount of US exposure i may add. They could get bigger by purchasing only with US based ops whether private or not. But like i said it COULD be WEED OR Tilray, which is mostly the US market. Hope this clarifies my comments.
GLTA